Changes in ghrelin, substance P and vasoactive intestinal peptide levels in the gastroduodenal mucosa of patients with morbid obesity

• Published in: Neuropeptides (Edinburgh) Vol. 89; p. 102164
• Main Authors: Atas, Unal, Erin, Nuray, Tazegul, Gokhan, Elpek, Gulsum Ozlem, Yildirim, Bulent
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01-10-2021; Elsevier Science Ltd
• Subjects: Adult; Body Mass Index; Duodenum; Duodenum - metabolism; Enzyme-linked immunosorbent assay; Female; Food intake; Gastric emptying; Gastric Mucosa - metabolism; Gastroduodenal tissue; Ghrelin; Ghrelin - blood; Ghrelin - metabolism; Humans; Immunoreactivity; Intestinal Mucosa - metabolism; Intestine; Male; Middle Aged; Morbid obesity; Mucosa; Obesity; Obesity, Morbid - blood; Obesity, Morbid - metabolism; Peptides; Stomach; Substance P; Substance P - metabolism; Vasoactive agents; Vasoactive intestinal peptide; Vasoactive Intestinal Peptide - metabolism; Gastroduodenal tissue; Morbid obesity; Ghrelin; Substance P; Vasoactive intestinal peptide
• ISSN: 0143-4179; 1532-2785
• DOI: 10.1016/j.npep.2021.102164

The aim of the study was to assess changes in levels of substance P (SP), vasoactive intestinal peptide (VIP) and ghrelin in the gastroduodenal mucosa of obese individuals, which has not been studied before.
Forty-six patients with a body mass index (BMI) of >40 kg/m2 and 20 patients with a BMI of 18–25 kg/m2 were included in the study. VIP and SP levels in the fundus, antrum and duodenal mucosa were measured in freshly frozen tissues using enzyme-linked immunosorbent assay (ELISA). Fasting levels of ghrelin in blood were also measured with ELISA. Tissue levels of ghrelin were assessed by immunohistochemical staining, and immunoreactivity scores were used for ghrelin evaluation in tissues.
Antrum SP levels were higher in the obese group than in the control group. A significant number of obese patients had low VIP levels in the fundus and antrum. Intense ghrelin staining was observed in a limited number of cells in the mucosal area of the gastric fundus that was similar in the control and patient groups. In the antrum and duodenum, ghrelin staining was low in all the samples examined.
Here, we found that SP levels are increased, while VIP levels are decreased in the antrum of morbidly obese individuals. Previous studies show that SP increases gastroduodenal motility, that VIP slows it down, and that the gastric emptying rate is higher in obese individuals, preventing negative feedback mechanisms upon food intake. Therefore, increases in SP and decreases in VIP levels in the antrum may contribute to obesity by accelerating gastric emptying.